Vaccine Update Newsletter: November 2024
Vaccine Resources: Nirsevimab Effectiveness, AI in Health Communication and Updated VISs
Find a report about the effectiveness of nirsevimab in preventing severe RSV illness in Alaska Native children. Learn about a recent CDC podcast focused on health communication, and see which VISs were recently updated.
On the bookshelf — Made to Stick: Why Some Ideas Survive and Others Die, by Chip Heath and Dan Heath
Learn how to better communicate ideas using the authors’ SUCCESs approach. Ideas that are Simple, Unexpected, Concrete, Credible, Emotional, and told through Stories are “made to stick.” Read about how Dr. Offit applied this approach in a memorable demonstration.
Technically Speaking: Celebrating 30 Years of Vaccines for Children
As Vaccines for Children (VFC) celebrates 30 years of protecting children from vaccine-preventable diseases, Mary Beth Koslap-Petraco, one of the first VFC coordinators in New York, shares her reflections on the start of the program.
In the Journals: An Intranasal Live Attenuated Pertussis Vaccine
Find out about a study of a live attenuated intranasal pertussis vaccine, including the findings compared with current pertussis vaccines.
News & Views — Vaccines and Governance: Navigating Federal and State Roles in Public Health
Read about the roles of the U.S. federal, state and local governments in implementing vaccine policy and find four areas where individuals can affect change.
From the Media: Measles Cases Increase 20% Worldwide
Measles is on the rise globally. Find out about the latest data, who’s most affected, and what can be done.